DNMT1 and myelodysplastic syndrome: Unlike DNMT1, somatic mutations in DNMT3A are prevalent in hematologic malignancies of myeloid and lymphoid lineage, including AML (~20%) and myelodysplastic syndromes (MDS; ~10%), and these mutations are associated with a poor prognosis [83].